{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:44:23Z","timestamp":1789875863596,"version":"4.0.1"},"reference-count":98,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"University of North Carolina Lineberger Cancer Control Education Program","award":["T32 CA057726"],"award-info":[{"award-number":["T32 CA057726"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>What are the associations between a history of cancer and outcomes after ART?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>Compared to women without cancer, on average, women with cancer had a lower return for embryo transfer and a lower likelihood of clinical pregnancy and live birth after ART.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>Small, single-institution studies have suggested that cancer and its treatment may negatively affect ART outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>We conducted a systematic review with meta-analysis of studies comparing ART outcomes between women with and without cancer. PubMed, Embase and Scopus were searched for original, English-language studies published up to June 2021.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>Inclusion criteria required reporting of ART outcomes after controlled ovarian stimulation (COS) among women with a history of cancer compared to women without cancer who used ART for any indication. Outcomes of interest ranged from duration of COS to likelihood of live birth after embryo transfer. Random-effects meta-analysis was used to calculate mean differences and odds ratios (ORs) with 95% CIs and 95% prediction intervals (PIs). We assessed heterogeneity by age-adjustment, referent group indication for ART, study location and among women with breast cancer and women who initiated ART before cancer treatment. We used visual inspection, Egger\u2019s test and the trim-and-fill method to assess funnel plot asymmetry.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>Of 6094 unique records identified, 42 studies met inclusion criteria, representing a median per study of 58 women with cancer (interquartile range (IQR) = 159) and 114 women without cancer (IQR\u2009=\u2009348). Compared to women without cancer, on average, women with cancer had a lower return for embryo transfer (OR: 0.22; 95% CI: 0.07, 0.74; 95% PI: 0.00, 64.98); lower likelihood of clinical pregnancy (OR: 0.51; 95% CI: 0.35, 0.73; 95% PI: 0.19, 1.35); and lower likelihood of live birth (OR: 0.56; 95% CI: 0.38, 0.83; 95% PI: 0.19, 1.69). Substantial among-study heterogeneity was observed for COS duration, gonadotropin dose, cycle cancellation, total oocytes and mature oocytes. Fertilization percentage showed less heterogeneity, but study-specific estimates were imprecise. Similarly, number of embryos showed less heterogeneity, and most studies estimated minimal differences by cancer history. Funnel plot asymmetry was observed for estradiol peak and oocyte maturation percentage.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>Appreciable confounding is possible in 11 studies that lacked adequate control for group differences in age, and among-study heterogeneity was observed for most outcomes. Lack of data limited our ability to assess how cancer clinical factors (e.g. cancers other than breast, cancer stage and treatment) and ART cycle characteristics (e.g. fresh versus frozen embryo transfers and use of gestational carriers) may affect outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>Women with cancer may be less likely to achieve pregnancy and live birth after embryo transfer. Further examination of reproductive outcomes and sources of heterogeneity among studies is warranted to improve evidence of the expected success of ART after a cancer diagnosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>This research was supported in part by R01 CA211093 and P30 ES010126. C.M. was supported by the University of North Carolina Lineberger Cancer Control Education Program (T32 CA057726) and the National Cancer Institute (F31 CA260787). J.A.R.-H. was supported by the National Cancer Institute (K08 CA234333, P30 CA016672). J.A.R.-H. reports receiving consulting fees from Schlesinger Group and Guidepoint. The remaining authors declare no competing interests.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>N\/A.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deac235","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T18:41:52Z","timestamp":1667846512000},"page":"30-45","source":"Crossref","is-referenced-by-count":17,"title":["Outcomes after assisted reproductive technology in women with cancer: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8564-1266","authenticated-orcid":false,"given":"Clare","family":"Meernik","sequence":"first","affiliation":[{"name":"Department of Population Health Sciences, Duke University School of Medicine , Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Poole","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Global Public Health , Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M","family":"Engel","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Global Public Health , Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Alejandro","family":"Rauh-Hain","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center , Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0405-8133","authenticated-orcid":false,"given":"Barbara","family":"Luke","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Biology, College of Human Medicine, Michigan State University , East Lansing, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel B","family":"Nichols","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Global Public Health , Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"key":"2023010801274938300_deac235-B1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humupd\/dmy038","article-title":"How can we improve oncofertility care for patients? A systematic scoping review of current international practice and models of care","volume":"25","author":"Anazodo","year":"2019","journal-title":"Hum Reprod Update"},{"key":"2023010801274938300_deac235-B2","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/humrep\/deac035","article-title":"Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis","volume":"37","author":"Arecco","year":"2022","journal-title":"Hum Reprod"},{"key":"2023010801274938300_deac235-B3000","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.fertnstert.2012.06.007","article-title":"Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation","volume":"98","author":"Almog","year":"2012","journal-title":"Fertil Steril"},{"key":"2023010801274938300_deac235-B3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.fertnstert.2011.11.028","article-title":"Female cancer survivors are low responders and have reduced success compared with other patients undergoing assisted reproductive technologies","volume":"97","author":"Barton","year":"2012","journal-title":"Fertil Steril"},{"key":"2023010801274938300_deac235-B1100","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/09513590.2018.1534950","article-title":"Effect of letrozole added to gonadotropins in controlled ovarianstimulation protocols on the yield and maturity of retrieved oocytes","volume":"35","author":"Ben-Haroush","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"2023010801274938300_deac235-B1300","first-page":"257","article-title":"The impact of letrozole administration on oocyte morphology in breast cancer patients undergoing fertility preservation","volume":"24","author":"Bercaire","year":"2020","journal-title":"JBRA Assist Reprod"},{"key":"2023010801274938300_deac235-B4","doi-asserted-by":"crossref","first-page":"574669","DOI":"10.3389\/fonc.2020.574669","article-title":"Efficacy and safety of controlled ovarian stimulation with or without letrozole co-administration for fertility preservation: a systematic review and meta-analysis","volume":"10","author":"Bonardi","year":"2020","journal-title":"Front Oncol"},{"key":"2023010801274938300_deac235-B5","doi-asserted-by":"crossref","first-page":"101925","DOI":"10.1016\/j.jogoh.2020.101925","article-title":"Ovarian response to stimulation for fertility preservation in women with hematologic cancer","volume":"50","author":"Brun","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"2023010801274938300_deac235-B6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10815-015-0428-z","article-title":"Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience","volume":"32","author":"Cardozo","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"2023010801274938300_deac235-B7","volume-title":"2017 Assisted Reproductive Technology Fertility Clinic Success Rates Report","author":"Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology","year":"2017"},{"key":"2023010801274938300_deac235-B8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3322\/caac.21585","article-title":"Adolescent and young adult oncology-past, present, and future","volume":"69","author":"Close","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"2023010801274938300_deac235-B9","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1093\/humrep\/dey321","article-title":"Elective and onco-fertility preservation: factors related to IVF outcomes","volume":"33","author":"Cobo","year":"2018","journal-title":"Hum Reprod"},{"key":"2023010801274938300_deac235-B10","doi-asserted-by":"crossref","first-page":"e1914511","DOI":"10.1001\/jamanetworkopen.2019.14511","article-title":"Clinicians\u2019 perspectives on barriers to discussing infertility and fertility preservation with young women with cancer","volume":"2","author":"Covelli","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2023010801274938300_deac235-B11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/jncimonographs\/lgi022","article-title":"Impact of cancer treatment on uterine function","volume":"2005","author":"Critchley","year":"2005","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2023010801274938300_deac235-B7398987","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.fertnstert.2011.04.070","article-title":"Ovarian reserve, response to gonadotropins, and oocyte maturity in women with malignancy","volume":"96","author":"Das","year":"2011","journal-title":"Fertil Steril"},{"key":"2023010801274938300_deac235-B12","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1093\/humrep\/des143","article-title":"Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapy","volume":"27","author":"Das","year":"2012","journal-title":"Hum Reprod"},{"key":"2023010801274938300_deac235-B8000","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.rbmo.2018.01.016","article-title":"Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls","volume":"36","author":"Decanter","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"2023010801274938300_deac235-B13","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1002\/cncr.29637","article-title":"Impact of fertility preservation counseling and treatment on psychological outcomes among women with cancer: a systematic review","volume":"121","author":"Deshpande","year":"2015","journal-title":"Cancer"},{"key":"2023010801274938300_deac235-B9000","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40738-018-0048-2","article-title":"Responses to fertility treatment among patients with cancer: a retrospective cohort study","volume":"4","author":"Dolinko","year":"2018","journal-title":"Fertil Res Pract"},{"key":"2023010801274938300_deac235-B14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.critrevonc.2019.03.010","article-title":"EUropean REcommendations for female FERtility preservation (EU-REFER): a joint collaboration between oncologists and fertility specialists","volume":"138","author":"Dolmans","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"2023010801274938300_deac235-B15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13048-014-0080-8","article-title":"Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes","volume":"7","author":"Dolmans","year":"2014","journal-title":"J Ovarian Res"},{"key":"2023010801274938300_deac235-B4000","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.fertnstert.2012.01.093","article-title":"Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment","volume":"97","author":"Domingo","year":"2012","journal-title":"Fertil Steril"},{"key":"2023010801274938300_deac235-B16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"2023010801274938300_deac235-B17","doi-asserted-by":"crossref","first-page":"hoaa052","DOI":"10.1093\/hropen\/hoaa052","article-title":"ESHRE guideline: female fertility preservation","volume":"2020","author":"ESHRE Guideline Group on Female Fertility Preservation","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2023010801274938300_deac235-B18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.fertnstert.2018.05.034","article-title":"Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion","volume":"110","author":"Ethics Committee of the American Society for Reproductive Medicine","year":"2018","journal-title":"Fertil Steril"},{"key":"2023010801274938300_deac235-B1800","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ijgo.13702","article-title":"Female fertility preservation: Impact of cancer on ovarian function and oocyte quality","volume":"156","author":"Fabiani","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"2023010801274938300_deac235-B19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.fertnstert.2011.10.014","article-title":"Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis","volume":"97","author":"Friedler","year":"2012","journal-title":"Fertil Steril"},{"key":"2023010801274938300_deac235-B20","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10815-014-0297-x","article-title":"The outcome of infertility treatment in patients undergoing assisted reproductive technology after conservative therapy for endometrial cancer","volume":"31","author":"Fujimoto","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"2023010801274938300_deac235-B21","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.fertnstert.2013.02.004","article-title":"Five years\u2019 experience using oocyte vitrification to preserve fertility for medical and nonmedical indications","volume":"99","author":"Garcia-Velasco","year":"2013","journal-title":"Fertil Steril"},{"key":"2023010801274938300_deac235-B22","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.ejca.2015.05.007","article-title":"Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome","volume":"51","author":"Goldrat","year":"2015","journal-title":"Eur J Cancer"},{"key":"2023010801274938300_deac235-B23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12958-018-0443-x","article-title":"Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers","volume":"17","author":"Goldrat","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"2023010801274938300_deac235-B24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/humupd\/dmz041","article-title":"Do cancer therapies damage the uterus and compromise fertility?","volume":"26","author":"Griffiths","year":"2020","journal-title":"Hum Reprod Update"},{"key":"2023010801274938300_deac235-B1200","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.fertnstert.2018.10.014","article-title":"BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation","volume":"111","author":"Gunnala","year":"2019","journal-title":"Fertil Steril"},{"key":"2023010801274938300_deac235-B25","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1002\/cncr.31732","article-title":"Pregnancy after cancer: does timing of conception affect infant health?","volume":"124","author":"Hartnett","year":"2018","journal-title":"Cancer"},{"key":"2023010801274938300_deac235-B26","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2021"},{"key":"2023010801274938300_deac235-B27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12958-021-00763-8","article-title":"Analysis of in vitro fertilization\/intracytoplasmic sperm injection outcomes in infertile women with a history of thyroid cancer: a retrospective study","volume":"19","author":"Huang","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"2023010801274938300_deac235-B28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ajog.2009.12.020","article-title":"Racial and ethnic disparities in reproductive endocrinology and infertility","volume":"202","author":"Huddleston","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"2023010801274938300_deac235-B1700","doi-asserted-by":"crossref","first-page":"101944","DOI":"10.1016\/j.jogoh.2020.101944","article-title":"Does type of cancer affect ovarian response in oncofertility patients?","volume":"50","author":"Hussein","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"2023010801274938300_deac235-B29","author":"International Agency for Research on Cancer","year":"2020"},{"key":"2023010801274938300_deac235-B30","doi-asserted-by":"crossref","first-page":"e010247","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"key":"2023010801274938300_deac235-B31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.rbmo.2013.01.003","article-title":"Response to ovarian stimulation in patients facing gonadotoxic therapy","volume":"26","author":"Johnson","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"2023010801274938300_deac235-B32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/humupd\/dmx009","article-title":"What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment?","volume":"23","author":"Jones","year":"2017","journal-title":"Hum Reprod Update"},{"key":"2023010801274938300_deac235-B33","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s10815-020-01829-z","article-title":"Is the probability of pregnancy after ovarian stimulation for IVF associated with serum estradiol levels on the day of triggering final oocyte maturation with hCG? A systematic review and meta-analysis","volume":"37","author":"Karatasiou","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"2023010801274938300_deac235-B1400","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10815-020-01715-8","article-title":"Oncologic oocyte cryopreservation: national comparison of fertility preservation between women with and without cancer","volume":"37","author":"Kawwass","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"2023010801274938300_deac235-B34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3346\/jkms.2015.30.3.290","article-title":"Efficacy of random-start controlled ovarian stimulation in cancer patients","volume":"30","author":"Kim","year":"2015","journal-title":"J Korean Med Sci"},{"key":"2023010801274938300_deac235-B50504699","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.fertnstert.2009.03.028","article-title":"Fertility preservation for female cancer patients: early clinical experience","volume":"94","author":"Klock","year":"2010","journal-title":"Fertil Steril"},{"key":"2023010801274938300_deac235-B6868117","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.fertnstert.2008.07.1727","article-title":"Women with cancer undergoing ART for fertility preservation: a cohort study of their response to exogenous gonadotropins","volume":"91","author":"Knopman","year":"2009","journal-title":"Fertil Steril"},{"key":"2023010801274938300_deac235-B35","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S1470-2045(09)70317-1","article-title":"Surviving childhood and reproductive-age malignancy: effects on fertility and future parenthood","volume":"11","author":"Knopman","year":"2010","journal-title":"Lancet Oncol"},{"key":"2023010801274938300_deac235-B36","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1093\/humrep\/deh473","article-title":"Association of estradiol levels on the day of hCG administration and pregnancy achievement in IVF: a systematic review","volume":"19","author":"Kosmas","year":"2004","journal-title":"Hum Reprod"},{"key":"2023010801274938300_deac235-B37","doi-asserted-by":"crossref","first-page":"655447","DOI":"10.3389\/fpubh.2021.655447","article-title":"Structural racism, health inequities, and the two-edged sword of data: structural problems require structural solutions","volume":"9","author":"Krieger","year":"2021","journal-title":"Front Public Health"},{"key":"2023010801274938300_deac235-B38","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1200\/JCO.21.00535","article-title":"Pregnancy after breast cancer: a systematic review and meta-analysis","volume":"39","author":"Lambertini","year":"2021","journal-title":"J Clin Oncol"},{"key":"2023010801274938300_deac235-B39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-015-0545-7","article-title":"Cancer and fertility preservation: international recommendations from an expert meeting","volume":"14","author":"Lambertini","year":"2016","journal-title":"BMC Med"},{"key":"2023010801274938300_deac235-B40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.breast.2018.08.099","article-title":"The BCY3\/BCC 2017 survey on physicians\u2019 knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients","volume":"42","author":"Lambertini","year":"2018","journal-title":"Breast"},{"key":"2023010801274938300_deac235-B41","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.annonc.2020.09.006","article-title":"Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines","volume":"31","author":"Lambertini","year":"2020","journal-title":"Ann Oncol"},{"key":"2023010801274938300_deac235-B42","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1200\/JCO.2006.06.5888","article-title":"American Society of Clinical Oncology recommendations on fertility preservation in cancer patients","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"2023010801274938300_deac235-B5000","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10815-016-0689-1","article-title":"Female patients with lymphoma demonstrate diminished ovarian reserve even before initiation of chemotherapy when compared with healthy controls and patients with other malignancies","volume":"33","author":"Lekovich","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"2023010801274938300_deac235-B43","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/cncr.29181","article-title":"Infertility in reproductive-age female cancer survivors","volume":"121","author":"Levine","year":"2015","journal-title":"Cancer"},{"key":"2023010801274938300_deac235-B44","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/pon.4518","article-title":"Clinician provision of oncofertility support in cancer patients of a reproductive age: a systematic review","volume":"27","author":"Logan","year":"2018","journal-title":"Psychooncology"},{"key":"2023010801274938300_deac235-B45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/pon.4927","article-title":"Systematic review of fertility-related psychological distress in cancer patients: informing on an improved model of care","volume":"28","author":"Logan","year":"2019","journal-title":"Psychooncology"},{"key":"2023010801274938300_deac235-B46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/humrep\/dev288","article-title":"Assisted reproductive technology use and outcomes among women with a history of cancer","volume":"31","author":"Luke","year":"2016","journal-title":"Hum Reprod"},{"key":"2023010801274938300_deac235-B47","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10815-016-0669-5","article-title":"Embryo banking among women diagnosed with cancer: a pilot population-based study in New York, Texas, and Illinois","volume":"33","author":"Luke","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"2023010801274938300_deac235-B48","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.fertnstert.2021.11.019","article-title":"Black race associated with lower live birth rate in frozen-thawed blastocyst transfer cycles: an analysis of 7,002 Society for Assisted Reproductive Technology frozen-thawed blastocyst transfer cycles","volume":"117","author":"Makhijani","year":"2021","journal-title":"Fertil Steril"},{"key":"2023010801274938300_deac235-B49","doi-asserted-by":"crossref","first-page":"i5735","DOI":"10.1136\/bmj.i5735","article-title":"Predicting the chances of a live birth after one or more complete cycles of in vitro fertilisation: population based study of linked cycle data from 113\u2009873 women","volume":"355","author":"McLernon","year":"2016","journal-title":"BMJ"},{"key":"2023010801274938300_deac235-B4729078","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejogrb.2009.12.023","article-title":"Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients","volume":"149","author":"Michaan","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2023010801274938300_deac235-B50","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.fertnstert.2010.12.041","article-title":"Ovarian reserve and oocyte maturity in women with malignancy undergoing in vitro maturation treatment","volume":"95","author":"Moria","year":"2011","journal-title":"Fertil Steril"},{"key":"2023010801274938300_deac235-B5050","first-page":"91","article-title":"Oocyte cryopreservation for future fertility: comparison of ovarian response between cancer and noncancer patients","volume":"23","year":"2019","journal-title":"JBRA Assist Reprod"},{"key":"2023010801274938300_deac235-B51","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S1470-2045(20)30594-5","article-title":"Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"22","author":"Mulder","year":"2021","journal-title":"Lancet Oncol"},{"key":"2023010801274938300_deac235-B1500","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11060-020-03429-4","article-title":"Fertility preservation outcomes in women with gliomas: a retrospective case-control study","volume":"147","author":"Nordan","year":"2020","journal-title":"J Neurooncol"},{"key":"2023010801274938300_deac235-B11553623","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10815-010-9434-3","article-title":"Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors","volume":"27","author":"Noyes","year":"2010","journal-title":"J Assist Reprod Genet"},{"key":"2023010801274938300_deac235-B6000","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/COC.0000000000000031","article-title":"Fertility Preservation Decisions Among Newly Diagnosed Oncology Patients: A Single-Center Experience","volume":"39","author":"Nurudeen","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"2023010801274938300_deac235-B39856303","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1210\/jc.2006-0962","article-title":"Letrozole Reduces Estrogen and Gonadotropin Exposure in Women with Breast Cancer Undergoing Ovarian Stimulation before Chemotherapy","volume":"91","author":"Oktay","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2023010801274938300_deac235-B52","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility preservation in patients with cancer: ASCO clinical practice guideline update","volume":"36","author":"Oktay","year":"2018","journal-title":"J Clin Oncol"},{"key":"2023010801274938300_deac235-B53","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2023010801274938300_deac235-B3814615","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/humrep\/13.7.1837","article-title":"Malignancy may adversely influence the quality and behaviour of oocytes","volume":"13","author":"Pal","year":"1998","journal-title":"Hum Reprod"},{"key":"2023010801274938300_deac235-B54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/0974-1208.138869","article-title":"Fertility preservation outcomes may differ by cancer diagnosis","volume":"7","author":"Pavone","year":"2014","journal-title":"J Hum Reprod Sci"},{"key":"2023010801274938300_deac235-B55","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1002\/sim.2889","article-title":"Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity","volume":"26","author":"Peters","year":"2007","journal-title":"Stat Med"},{"key":"2023010801274938300_deac235-B7000","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/09513590.2016.1177013","article-title":"Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes\u2020","volume":"32","author":"Pereira","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"2023010801274938300_deac235-B56","doi-asserted-by":"crossref","first-page":"pkz008","DOI":"10.1093\/jncics\/pkz008","article-title":"Cancer treatment-related infertility: a critical review of the evidence","volume":"3","author":"Poorvu","year":"2019","journal-title":"JNCI Cancer Spectr"},{"key":"2023010801274938300_deac235-B1600","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10815-019-01658-9","article-title":"Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer","volume":"37","author":"Porcu","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"2023010801274938300_deac235-B57","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.fertnstert.2019.09.013","article-title":"Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion","volume":"112","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2019","journal-title":"Fertil Steril"},{"key":"2023010801274938300_deac235-B58","first-page":"568","article-title":"Response to ovarian stimulation is not impacted by a breast cancer diagnosis","volume":"32","author":"Quinn","year":"2017","journal-title":"Hum Reprod"},{"key":"2023010801274938300_deac235-B59","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.fertnstert.2008.10.007","article-title":"Ovarian stimulation for fertility preservation in patients with cancer","volume":"93","author":"Quintero","year":"2010","journal-title":"Fertil Steril"},{"key":"2023010801274938300_deac235-B60","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"key":"2023010801274938300_deac235-B6800263","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.fertnstert.2010.04.028","article-title":"Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy","volume":"95","author":"Robertson","year":"2011","journal-title":"Fertil Steril"},{"key":"2023010801274938300_deac235-B61","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/aogs.13559","article-title":"A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients\u2019 choices and benefit of the chosen methods after long-term follow up","volume":"98","author":"Rodriguez-Wallberg","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2023010801274938300_deac235-B62","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10815-010-9515-3","article-title":"Pronuclear embryo cryopreservation experience: outcomes for reducing the risk of ovarian hyperstimulation syndrome and for fertility preservation in cancer patients","volume":"28","author":"Sabatini","year":"2011","journal-title":"J Assist Reprod Genet"},{"key":"2023010801274938300_deac235-B63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12958-020-00662-4","article-title":"Status of racial disparities between black and white women undergoing assisted reproductive technology in the US","volume":"18","author":"Seifer","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"2023010801274938300_deac235-B64","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dmz027","article-title":"Ovarian damage from chemotherapy and current approaches to its protection","volume":"25","author":"Spears","year":"2019","journal-title":"Hum Reprod Update"},{"key":"2023010801274938300_deac235-B65","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis","volume":"53","author":"Sterne","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"2023010801274938300_deac235-B66","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"2023010801274938300_deac235-B67","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ijgo.13529","article-title":"Reduced response to controlled ovarian stimulation after radical trachelectomy: a pitfall of fertility-sparing surgery for cervical cancer","volume":"154","author":"Tamauchi","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"2023010801274938300_deac235-B1010","doi-asserted-by":"crossref","first-page":"e12797","DOI":"10.1111\/ecc.12797","article-title":"Ovarian response to controlled ovarian stimulation for fertility preservation before oncology treatment: A retrospective cohort of 157 patients","volume":"27","author":"Tsampras","year":"2018","journal-title":"Eur J Cancer Care (Engl)"},{"key":"2023010801274938300_deac235-B68","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.fertnstert.2018.08.013","article-title":"The impact of malignancy on response to ovarian stimulation for fertility preservation: a meta-analysis","volume":"110","author":"Turan","year":"2018","journal-title":"Fertil Steril"},{"key":"2023010801274938300_deac235-B69","author":"U.S. Preventive Services Task Force","year":"2021"},{"key":"2023010801274938300_deac235-B70","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/humupd\/dmq015","article-title":"Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis","volume":"16","author":"van Loendersloot","year":"2010","journal-title":"Hum Reprod Update"},{"key":"2023010801274938300_deac235-B71","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2023010801274938300_deac235-B804862","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10815-010-9455-y","article-title":"Laboratory evaluation in oocyte cryopreservation suggests retrieved oocytes are comparable whether frozen for medical indications, deferred reproduction or oocyte donation","volume":"27","author":"Werner","year":"2010","journal-title":"J Assist Reprod Genet"},{"key":"2023010801274938300_deac235-B72","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.ijrobp.2008.12.016","article-title":"Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients","volume":"73","author":"Wo","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/38\/1\/30\/48445579\/deac235.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/38\/1\/30\/48445579\/deac235.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T01:29:30Z","timestamp":1673141370000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/38\/1\/30\/6808914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,11,7]]},"published-print":{"date-parts":[[2023,1,5]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deac235","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,11,7]]}}}